Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Current Leases (2023 - 2026)

Beta Bionics' Current Leases history spans 4 years, with the latest figure at $1.8 million for Q1 2026.

  • On a quarterly basis, Current Leases rose 20.67% to $1.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.8 million, a 20.67% increase, with the full-year FY2025 number at $1.9 million, up 26.75% from a year prior.
  • Current Leases hit $1.8 million in Q1 2026 for Beta Bionics, down from $1.9 million in the prior quarter.
  • Over the last five years, Current Leases for BBNX hit a ceiling of $2.0 million in Q3 2025 and a floor of $1.2 million in Q4 2023.
  • Historically, Current Leases has averaged $1.7 million across 4 years, with a median of $1.5 million in 2024.
  • Biggest five-year swings in Current Leases: rose 26.75% in 2025 and later increased 20.67% in 2026.
  • Tracing BBNX's Current Leases over 4 years: stood at $1.2 million in 2023, then grew by 24.92% to $1.5 million in 2024, then rose by 26.75% to $1.9 million in 2025, then decreased by 5.11% to $1.8 million in 2026.
  • Business Quant data shows Current Leases for BBNX at $1.8 million in Q1 2026, $1.9 million in Q4 2025, and $2.0 million in Q3 2025.